Notably, a significantly elevated expression of BCL2, which functions as an apoptosis inhibitor, and TNFα was found in the high TNMD subgroup, indicating these COPD patients were characterized by anoikis resistance. This evidence concerns the gene BCL2 and chronic obstructive pulmonary disease.